A failed antidepressant turns out to have a side-effect that could improve the sex lives of women with low libido. A reduction in sex drive affects between one in ten and one in four women depending on age and whether they have been through the menopause. German pharmaceutical company Boehringer Ingelheim claims that its drug, flibanserin, "boosted" satisfying sexual activity in female participants in a trial of the antidepressant. A daily 100 milligram dose apparently increased satisfying sexual events per month from about 3 to between 4 and 5, on average. Placebo also increased such events to almost 4 per month, on average. Such figures do not fill all observers with confidence, especially those who see the medicalization of normal life as a serious problem of the modern industry.
One for the ladies?